Vor Biopharma Inc. (VOR) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$371.64M | -206.7% |
| 2024 | -$121.19M | +3.8% |
| 2023 | -$126.04M | -34.9% |
| 2022 | -$93.42M | -35.4% |
| 2021 | -$69.02M | -59.2% |
| 2020 | -$43.37M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$371.64M | -206.7% |
| 2024 | -$121.19M | +3.8% |
| 2023 | -$126.04M | -34.9% |
| 2022 | -$93.42M | -35.4% |
| 2021 | -$69.02M | -59.2% |
| 2020 | -$43.37M | — |